Verve Therapeutics Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
13:11
Jan 08
Jan 08
Beam and Verve show base-editing success
Beam Therapeutics and Verve Therapeutics are advancing base editing, which modifies a patient's existing gene rather than delivering a whole gene, and this technology has shown very good success in clinical development.
MED
About Verve Therapeutics Investor Commentary
Across the available history and selected sources, Buzzberg tracks Verve Therapeutics across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Scott Gottlieb.